Chen Y, Liu S, Papageorgiou L, Theofilatos K, Tsoka S
Cancers (Basel). 2023; 15(6).
PMID: 36980673
PMC: 10046797.
DOI: 10.3390/cancers15061787.
Zavala V, Serrano-Gomez S, Dutil J, Fejerman L
Genes (Basel). 2019; 10(2).
PMID: 30781715
PMC: 6410045.
DOI: 10.3390/genes10020153.
Ujvari B, Klaassen M, Raven N, Russell T, Vittecoq M, Hamede R
Proc Biol Sci. 2018; 285(1875).
PMID: 29563261
PMC: 5897632.
DOI: 10.1098/rspb.2017.2589.
Moghaddam A, Nazarzadeh M, Noroozi R, Darvish H, Mosavi Jarrahi A
Iran J Cancer Prev. 2016; 9(1):e3467.
PMID: 27366307
PMC: 4922200.
DOI: 10.17795/ijcp-3467.
Otterpohl K, Gould K
Mamm Genome. 2015; 26(5-6):235-47.
PMID: 25976411
DOI: 10.1007/s00335-015-9567-x.
Polymorphysims of CYP17-I Gene in the Exons Were Associated with the Reproductive Endocrine of Japanese Flounder (Paralichthys olivaceus).
Ma R, He F, Wen H, Li J, Mu W, Liu M
Asian-Australas J Anim Sci. 2014; 25(6):794-9.
PMID: 25049628
PMC: 4093092.
DOI: 10.5713/ajas.2011.11489.
Aberrant promoter hypermethylation of p21 (WAF1/CIP1) gene and its impact on expression and role of polymorphism in the risk of breast cancer.
Askari M, Sobti R, Nikbakht M, Sharma S
Mol Cell Biochem. 2013; 382(1-2):19-26.
PMID: 24005533
DOI: 10.1007/s11010-013-1696-5.
Epistatic interaction of Arg72Pro TP53 and -710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival.
Rodrigues P, Furriol J, Tormo E, Ballester S, Lluch A, Eroles P
Mol Cell Biochem. 2013; 379(1-2):181-90.
PMID: 23716179
DOI: 10.1007/s11010-013-1640-8.
Genetic variants of EGFR (142285G>A) and ESR1 (2014G>A) gene polymorphisms and risk of breast cancer.
Sobti R, Askari M, Nikbakht M, Singh N, Sharma S, Abitew A
Mol Cell Biochem. 2012; 369(1-2):217-25.
PMID: 22810499
DOI: 10.1007/s11010-012-1384-x.
Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent.
de Cassia Carvalho Barbosa R, Menezes D, Freire T, Sales D, Medeiros Alencar V, Rabenhorst S
Mol Biol Rep. 2011; 39(4):4899-907.
PMID: 22134752
DOI: 10.1007/s11033-011-1285-1.
Genetic variation in the promoter of DNMT3B is associated with the risk of colorectal cancer.
Bao Q, He B, Pan Y, Tang Z, Zhang Y, Qu L
Int J Colorectal Dis. 2011; 26(9):1107-12.
PMID: 21519807
DOI: 10.1007/s00384-011-1199-3.
Somatic mutations in cancer development.
Luzzatto L
Environ Health. 2011; 10 Suppl 1:S12.
PMID: 21489208
PMC: 3073190.
DOI: 10.1186/1476-069X-10-S1-S12.
IL-8-251A>T polymorphism is associated with breast cancer risk: a meta-analysis.
Huang Q, Wang C, Qiu L, Shao F, Yu J
J Cancer Res Clin Oncol. 2011; 137(7):1147-50.
PMID: 21468699
DOI: 10.1007/s00432-011-0981-5.
Ownership of uncertainty: healthcare professionals counseling and treating women from hereditary breast and ovarian cancer families who receive an inconclusive BRCA1/2 genetic test result.
Kenen R, Ardern-Jones A, Lynch E, Eeles R
Genet Test Mol Biomarkers. 2011; 15(4):243-50.
PMID: 21254913
PMC: 3064637.
DOI: 10.1089/gtmb.2010.0071.
Mutagen sensitivity, tobacco smoking and breast cancer risk: a case-control study.
Kosti O, Byrne C, Meeker K, Watkins K, Loffredo C, Shields P
Carcinogenesis. 2010; 31(4):654-9.
PMID: 20110285
PMC: 2847093.
DOI: 10.1093/carcin/bgq017.
Genetic sequence variations and ADPRT haplotype analysis in French Canadian families with high risk of breast cancer.
Durocher F, Labrie Y, Ouellette G, Simard J
J Hum Genet. 2007; 52(12):963-977.
PMID: 17943227
DOI: 10.1007/s10038-007-0203-9.
Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P
BMC Cancer. 2006; 6:230.
PMID: 17010193
PMC: 1599749.
DOI: 10.1186/1471-2407-6-230.
Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County.
Margolin S, Johansson H, Rutqvist L, Lindblom A, Fornander T
Fam Cancer. 2006; 5(4):309-21.
PMID: 16858627
DOI: 10.1007/s10689-006-7851-3.
Genetic polymorphisms in DPF3 associated with risk of breast cancer and lymph node metastases.
Hoyal C, Kammerer S, Roth R, Reneland R, Marnellos G, Kiechle M
J Carcinog. 2005; 4:13.
PMID: 16109180
PMC: 1215495.
DOI: 10.1186/1477-3163-4-13.
Towards an integrated model for breast cancer etiology: the crucial role of the number of mammary tissue-specific stem cells.
Trichopoulos D, Lagiou P, Adami H
Breast Cancer Res. 2005; 7(1):13-7.
PMID: 15642176
PMC: 1064112.
DOI: 10.1186/bcr966.